
Axcan Pharma Inc. — Investor Relations & Filings
Axcan Pharma Inc. was a specialty pharmaceutical company focused on the development and commercialization of prescription products for diseases and disorders involving the digestive system. The company specialized in providing effective therapies for a range of gastrointestinal conditions, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and cholestatic diseases. Axcan marketed a broad line of products, such as pancrelipase capsules, aimed at improving the quality of care for patients suffering from chronic GI ailments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Material change report - English.pdf | 2008-02-26 | English | |
| Other securityholders documents - English.PDF | 2008-01-14 | English | |
| Material change report - French.PDF | 2007-12-04 | English | |
| Other.pdf | 2007-10-10 | English | |
| Material change report - English.pdf | 2007-08-07 | English | |
| Other.pdf | 2007-07-04 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2008
2 filings
| |||||
| 47821459 | Material change report - English.pdf | 2008-02-26 | English | ||
| 47821461 | Other securityholders documents - English.PDF | 2008-01-14 | English | ||
|
2007
7 filings
| |||||
| 47821463 | Material change report - French.PDF | 2007-12-04 | English | ||
| 47821465 | Other.pdf | 2007-10-10 | English | ||
| 47821467 | Material change report - English.pdf | 2007-08-07 | English | ||
| 47821469 | Other.pdf | 2007-07-04 | English | ||
| 47821471 | Other.pdf | 2007-06-21 | English | ||
| 47821473 | Material change report - English.pdf | 2007-06-14 | English | ||
| 47821476 | Other.pdf | 2007-05-14 | English | ||
|
2006
6 filings
| |||||
| 47821480 | Material change report - English.pdf | 2006-12-19 | English | ||
| 47821482 | Material change report - English.pdf | 2006-12-11 | English | ||
| 47821484 | Material change report - English.pdf | 2006-09-25 | English | ||
| 47821486 | Material change report - English.pdf | 2006-05-11 | English | ||
| 47821651 | Material change report - English.pdf | 2006-05-08 | English | ||
| 47821653 | Material change report - English.pdf | 2006-02-23 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CHOONG ANG VACCINE LABORATORY
Develops and manufactures vaccines, pharmaceuticals, and fe…
|
072020 | KR | Manufacturing |
|
CHOSA Oncology AB
Develops diagnostics and therapeutics for platinum-based ch…
|
CHOSA | SE | Manufacturing |
|
CHUGAI PHARMACEUTICAL CO., LTD.
A research-driven pharmaceutical company developing innovat…
|
4519 | JP | Manufacturing |
|
CHUKYOIYAKUHIN CO.,LTD.
Offers health products and pharmaceuticals via a direct-to-…
|
4558 | JP | Manufacturing |
|
Cian Healthcare Limited
WHO-GMP certified manufacturer of diverse healthcare produc…
|
542678 | IN | Manufacturing |
|
Cidara Therapeutics, Inc.
Develops targeted immunotherapies and anti-infectives for s…
|
CDTX | US | Manufacturing |
|
CILO CYBIN HOLDINGS LIMITED
Vertically integrated medical cannabis company with GACP cu…
|
CCCE | ZA | Manufacturing |
|
Cinclus Pharma Holding AB
Clinical-stage pharma company developing a PCAB for gastric…
|
CINPHA | SE | Manufacturing |
|
Cingulate Inc.
A clinical-stage biopharma firm developing treatments for A…
|
CING | US | Manufacturing |
|
Cipher Pharmaceuticals Inc.
Specialty pharmaceutical company acquiring and marketing pr…
|
CPHRF | CA | Manufacturing |
Axcan Pharma Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/43169/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=43169 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=43169 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=43169 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 43169}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Axcan Pharma Inc. (id: 43169)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.